An overview of the design and conduct of the BATTLE trials

Suyu Liu1, J Jack Lee2

  • 1Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Chinese Clinical Oncology
|September 27, 2015
PubMed

Insights

The Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trials show that biomarker-based adaptive trials are feasible for developing personalized lung cancer therapies. These trials advance targeted treatment strategies for non-small cell lung cancer.

Area of Science:

  • Biomedicine
  • Genomics
  • Oncology

Background:

  • Advances in biomedicine and genomics are enabling personalized cancer medicine.
  • Lung cancer treatment has historically relied on broad approaches, necessitating more targeted strategies.

Purpose of the Study:

  • To describe the design and conduct of the BATTLE-1 and BATTLE-2 trials.
  • To summarize key findings and lessons learned from these biomarker-based adaptive trials.
  • To evaluate the feasibility and promise of novel clinical trial platforms for targeted cancer therapy.

Main Methods:

  • Prospective, biopsy-mandated, biomarker-based, adaptive randomized clinical trials.
  • Focus on patients with advanced non-small cell lung cancer (NSCLC).
  • Refinement of clinical trial design in the ongoing BATTLE-2 trial.

Main Results:

  • The BATTLE program demonstrated the feasibility of its adaptive trial design.
  • Biomarker-based approaches show promise for identifying effective targeted therapies.
  • The trials represent a step towards personalized medicine in lung cancer treatment.

Conclusions:

  • Biomarker-driven adaptive clinical trials are effective for advancing targeted lung cancer therapy.
  • The BATTLE program provides a successful model for personalized cancer medicine development.
  • Further refinement of trial design can enhance the discovery of novel targeted therapies.

Related Concept Videos

Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.1K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
387
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Robbers Cave04:49

Robbers Cave

During the 1950s, the landmark Robbers Cave experiment demonstrated that when groups must compete with one another, intergroup conflict, hostility, and even violence may result. At the Oklahoman summer camp, two troops of boys—termed the Rattlers and the Eagles—took part in a week-long tournament. During this time, their negativity culminated in derogatory name-calling, fistfights, and even vandalism and destruction of property. However, this work also revealed that such tension...
15.1K
Group Design02:01

Group Design

The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
11.0K
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.7K